$LSBK
LAKE SHORE BANCORP, INC.

2023 Q2 Form 10-Q Financial Statement

#000134131823000032 Filed on May 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $8.470M $7.951M
YoY Change 31.71% 33.99%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $205.0K $195.0K
YoY Change -5.96% -15.58%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $2.256M $1.660M
YoY Change 398.01% 256.22%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $1.053M $1.953M
YoY Change -47.9% 54.02%
Income Tax $237.0K $269.0K
% Of Pretax Income 22.51% 13.77%
Net Earnings $816.0K $1.684M
YoY Change -51.54% 58.72%
Net Earnings / Revenue 9.63% 21.18%
Basic Earnings Per Share $0.14 $0.29
Diluted Earnings Per Share $0.14 $0.29
COMMON SHARES
Basic Shares Outstanding 5.693M 5.695M
Diluted Shares Outstanding 5.846M 5.882M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $101.0M $112.5M
YoY Change -3.57% -2.46%
Cash & Equivalents $35.58M $38.74M
Short-Term Investments $65.38M $73.75M
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $8.209M $8.237M
YoY Change -3.18% -4.69%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $714.0M $730.3M
YoY Change 2.81% 3.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $2.030M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.030M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $8.863M $8.093M
YoY Change 20.7% 5.57%
Total Long-Term Liabilities $8.863M $8.093M
YoY Change 20.7% 5.57%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.030M
Total Long-Term Liabilities $8.863M $8.093M
Total Liabilities $630.6M $647.0M
YoY Change 2.73% 3.55%
SHAREHOLDERS EQUITY
Retained Earnings $76.64M $75.82M
YoY Change 5.4% 6.28%
Common Stock $31.52M $31.51M
YoY Change 0.12% 0.21%
Preferred Stock
YoY Change
Treasury Stock (at cost) $13.72M $13.69M
YoY Change 1.45% 2.15%
Treasury Stock Shares $1.143M
Shareholders Equity $83.39M $83.32M
YoY Change
Total Liabilities & Shareholders Equity $714.0M $730.3M
YoY Change 2.81% 3.23%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $816.0K $1.684M
YoY Change -51.54% 58.72%
Depreciation, Depletion And Amortization $205.0K $195.0K
YoY Change -5.96% -15.58%
Cash From Operating Activities $1.986M $1.399M
YoY Change -26.2% -0.92%
INVESTING ACTIVITIES
Capital Expenditures $177.0K $146.0K
YoY Change -421.82% 6.57%
Acquisitions
YoY Change
Other Investing Activities $12.16M -$25.00K
YoY Change 156.64% -99.93%
Cash From Investing Activities $11.98M -$171.0K
YoY Change 155.87% -99.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $950.0K
YoY Change
Cash From Financing Activities -17.12M 27.88M
YoY Change 55.9% -1932.87%
NET CHANGE
Cash From Operating Activities 1.986M 1.399M
Cash From Investing Activities 11.98M -171.0K
Cash From Financing Activities -17.12M 27.88M
Net Change In Cash -3.157M 29.11M
YoY Change -12.55% -179.05%
FREE CASH FLOW
Cash From Operating Activities $1.986M $1.399M
Capital Expenditures $177.0K $146.0K
Free Cash Flow $1.809M $1.253M
YoY Change -34.12% -1.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001341318
CY2022 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201613Member
CY2022 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201613Member
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-51821
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
LAKE SHORE BANCORP, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
X1
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-4729288
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
31 East Fourth Street
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Dunkirk
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
14048
CY2023Q1 dei City Area Code
CityAreaCode
716
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
366-4070
CY2023Q1 dei Security12b Title
Security12bTitle
Common stock, par value $0.01 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
LSBK
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5693358
CY2023Q1 us-gaap Cash And Due From Banks
CashAndDueFromBanks
5481000
CY2022Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
9091000
CY2023Q1 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
33258000
CY2022Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
542000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38739000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9633000
CY2023Q1 us-gaap Marketable Securities
MarketableSecurities
73751000
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
73047000
CY2023Q1 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
2498000
CY2022Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
2330000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
6708000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
7065000
CY2023Q1 us-gaap Notes Receivable Net
NotesReceivableNet
574408000
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
573537000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8237000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8286000
CY2023Q1 us-gaap Interest Receivable
InterestReceivable
2832000
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
2796000
CY2023Q1 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
23323000
CY2022Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
23218000
CY2023Q1 us-gaap Other Assets
OtherAssets
6527000
CY2022Q4 us-gaap Other Assets
OtherAssets
7067000
CY2023Q1 us-gaap Assets
Assets
730315000
CY2022Q4 us-gaap Assets
Assets
699914000
CY2023Q1 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
498596000
CY2022Q4 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
464441000
CY2023Q1 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
96611000
CY2022Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
105678000
CY2023Q1 us-gaap Deposits
Deposits
595207000
CY2022Q4 us-gaap Deposits
Deposits
570119000
CY2023Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
2030000
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
12596000
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
39250000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
24950000
CY2023Q1 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
2420000
CY2022Q4 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
3308000
CY2023Q1 us-gaap Other Liabilities
OtherLiabilities
8093000
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
7757000
CY2023Q1 us-gaap Liabilities
Liabilities
647000000
CY2022Q4 us-gaap Liabilities
Liabilities
618730000
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6836514
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5693358
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6836514
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5705225
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
68000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
68000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
31439000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
31459000
CY2023Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
1143156
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1131289
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
13693000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
13571000
CY2023Q1 lsbk Unearned Esop Shares Cost
UnearnedEsopSharesCost
1087000
CY2022Q4 lsbk Unearned Esop Shares Cost
UnearnedEsopSharesCost
1108000
CY2023Q1 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
153000
CY2022Q4 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
191000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
75820000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
74859000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-9079000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-10332000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
83315000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
81184000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
730315000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
699914000
CY2023Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
7247000
CY2022Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
5420000
CY2023Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
228000
CY2022Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
189000
CY2023Q1 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
310000
CY2022Q1 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
310000
CY2023Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
166000
CY2022Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
15000
CY2023Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
7951000
CY2022Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
5934000
CY2023Q1 us-gaap Interest Expense Domestic Deposits
InterestExpenseDomesticDeposits
1313000
CY2022Q1 us-gaap Interest Expense Domestic Deposits
InterestExpenseDomesticDeposits
347000
CY2023Q1 us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Short Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesShortTerm
78000
CY2023Q1 us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm
256000
CY2022Q1 us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm
104000
CY2023Q1 us-gaap Interest Expense Other
InterestExpenseOther
13000
CY2022Q1 us-gaap Interest Expense Other
InterestExpenseOther
15000
CY2023Q1 us-gaap Interest Expense
InterestExpense
1660000
CY2022Q1 us-gaap Interest Expense
InterestExpense
466000
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
6291000
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
5468000
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-625000
CY2022Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
400000
CY2023Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
6916000
CY2022Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
5068000
CY2023Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
105000
CY2022Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
98000
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
1000
CY2022Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-1000
CY2023Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-49000
CY2022Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
183000
CY2023Q1 lsbk Recovery On Previously Impaired Investment Securities
RecoveryOnPreviouslyImpairedInvestmentSecurities
2000
CY2022Q1 lsbk Recovery On Previously Impaired Investment Securities
RecoveryOnPreviouslyImpairedInvestmentSecurities
6000
CY2022Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
-12000
CY2023Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
17000
CY2022Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
16000
CY2023Q1 us-gaap Noninterest Income
NoninterestIncome
554000
CY2022Q1 us-gaap Noninterest Income
NoninterestIncome
732000
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2779000
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2407000
CY2023Q1 us-gaap Occupancy Net
OccupancyNet
797000
CY2022Q1 us-gaap Occupancy Net
OccupancyNet
757000
CY2023Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
378000
CY2022Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
315000
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
850000
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
299000
CY2023Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
178000
CY2022Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
136000
CY2023Q1 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
95000
CY2022Q1 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
45000
CY2023Q1 lsbk Esop Shares Earned
ESOPSharesEarned
1984
CY2023Q1 us-gaap Amortization Of Esop Award
AmortizationOfESOPAward
22000
CY2023Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
8282
CY2023Q1 lsbk Compensation Plan Shares Earned
CompensationPlanSharesEarned
2510
CY2023Q1 lsbk Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value Earned Shares
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValueEarnedShares
-49000
CY2023Q1 us-gaap Supplies And Postage Expense
SuppliesAndPostageExpense
68000
CY2022Q1 us-gaap Supplies And Postage Expense
SuppliesAndPostageExpense
54000
CY2023Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
372000
CY2022Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
519000
CY2023Q1 us-gaap Noninterest Expense
NoninterestExpense
5517000
CY2022Q1 us-gaap Noninterest Expense
NoninterestExpense
4532000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1953000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1268000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
269000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
207000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1684000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1061000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.16
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1684000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1061000
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1255000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-6129000
CY2023Q1 lsbk Other Comprehensive Income Loss Reclassification Adjustment For Recovery On Previously Impaired Investments Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForRecoveryOnPreviouslyImpairedInvestmentsIncludedInNetIncomeNetOfTax
2000
CY2022Q1 lsbk Other Comprehensive Income Loss Reclassification Adjustment For Recovery On Previously Impaired Investments Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForRecoveryOnPreviouslyImpairedInvestmentsIncludedInNetIncomeNetOfTax
5000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1253000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6134000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2937000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5073000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
87976000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1061000
CY2022Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-1630000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6134000
CY2022Q1 lsbk Esop Shares Earned
ESOPSharesEarned
1984
CY2022Q1 us-gaap Amortization Of Esop Award
AmortizationOfESOPAward
30000
CY2022Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
27132
CY2022Q1 lsbk Compensation Plan Shares Earned
CompensationPlanSharesEarned
2749
CY2022Q1 lsbk Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value Earned Shares
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValueEarnedShares
42000
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.16
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
312000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
82663000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
81184000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1684000
CY2023Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
333000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1253000
CY2023Q1 us-gaap Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
15385
CY2023Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
4764
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
56000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
83315000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1684000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1061000
CY2023Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-14000
CY2022Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-35000
CY2023Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-141000
CY2022Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-90000
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-625000
CY2022Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
400000
CY2023Q1 lsbk Recovery On Previously Impaired Investment Securities
RecoveryOnPreviouslyImpairedInvestmentSecurities
2000
CY2022Q1 lsbk Recovery On Previously Impaired Investment Securities
RecoveryOnPreviouslyImpairedInvestmentSecurities
6000
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
1000
CY2022Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-1000
CY2023Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-49000
CY2022Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
183000
CY2022Q1 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
1002000
CY2022Q1 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
990000
CY2022Q1 lsbk Gain Loss On Sale Of Loans Held For Sale
GainLossOnSaleOfLoansHeldForSale
-12000
CY2023Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
195000
CY2022Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
231000
CY2023Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
105000
CY2022Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
98000
CY2023Q1 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
22000
CY2022Q1 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
30000
CY2023Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
-49000
CY2022Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
42000
CY2023Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
36000
CY2022Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-52000
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-409000
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-76000
CY2022Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
1000
CY2023Q1 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-297000
CY2022Q1 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-320000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1399000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1412000
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
871000
CY2022Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
2603000
CY2022Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
5526000
CY2023Q1 us-gaap Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
1248000
CY2023Q1 us-gaap Proceeds From Sale Of Federal Home Loan Bank Stock
ProceedsFromSaleOfFederalHomeLoanBankStock
1080000
CY2023Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
728000
CY2022Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
33686000
CY2022Q1 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
36000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
146000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
137000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-171000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-36710000
CY2023Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
25088000
CY2022Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-364000
CY2023Q1 lsbk Net Decrease Increase In Advances From Borrowers For Taxes And Insurance
NetDecreaseIncreaseInAdvancesFromBorrowersForTaxesAndInsurance
-888000
CY2022Q1 lsbk Net Decrease Increase In Advances From Borrowers For Taxes And Insurance
NetDecreaseIncreaseInAdvancesFromBorrowersForTaxesAndInsurance
-845000
CY2023Q1 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-10566000
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
15250000
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
950000
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
56000
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
312000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
27878000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1521000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
29106000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-36819000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9633000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
67585000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38739000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30766000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
1489000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
468000
CY2022Q1 us-gaap Real Estate Acquisitions Through Foreclosures
RealEstateAcquisitionsThroughForeclosures
116000
CY2022Q1 lsbk Securities Purchased And Not Yet Settled
SecuritiesPurchasedAndNotYetSettled
615000
CY2022Q4 us-gaap Net Investment In Lease Accrued Interest After Allowance For Credit Loss
NetInvestmentInLeaseAccruedInterestAfterAllowanceForCreditLoss
2400000
CY2023Q1 us-gaap Net Investment In Lease Accrued Interest After Allowance For Credit Loss
NetInvestmentInLeaseAccruedInterestAfterAllowanceForCreditLoss
2400000
CY2023Q1 us-gaap Financing Receivable Accrued Interest After Allowance For Credit Loss
FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss
435000
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
85257000
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
125000
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
11631000
CY2023Q1 us-gaap Marketable Securities
MarketableSecurities
73751000
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
86140000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
114000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
13207000
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
73047000
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
6835000
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
162000
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
56874000
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
11456000
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
63709000
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
11618000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
21041000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
1699000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
44820000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
11494000
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
65861000
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
13193000
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
23
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
159
CY2022Q1 us-gaap Availableforsale Securities Sold At Par
AvailableforsaleSecuritiesSoldAtPar
0
CY2023Q1 us-gaap Availableforsale Securities Sold At Par
AvailableforsaleSecuritiesSoldAtPar
0
CY2023Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
577238000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
576709000
CY2023Q1 us-gaap Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount
FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
3878000
CY2022Q4 us-gaap Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount
FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
3893000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
6708000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
7065000
CY2023Q1 us-gaap Notes Receivable Net
NotesReceivableNet
574408000
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
573537000
CY2023Q1 lsbk Loan Pledged As Collateral
LoanPledgedAsCollateral
150000000.0
CY2022 lsbk Loan Pledged As Collateral
LoanPledgedAsCollateral
147400000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
7065000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
16000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
2000
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-625000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
6708000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
6708000
CY2023Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
577238000
CY2023Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
164000
CY2023Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
577074000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
6708000
CY2023Q1 us-gaap Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount
FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
3878000
CY2021Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
6118000
CY2022Q1 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
20000
CY2022Q1 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
2000
CY2022Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
400000
CY2022Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
6500000
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
6500000
CY2022Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
553230000
CY2022Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
7226000
CY2022Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
546004000
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
6500000
CY2022Q1 us-gaap Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount
FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
3556000
CY2022Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
7065000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
7065000
CY2022Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
576709000
CY2022Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
167000
CY2022Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
576542000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
7065000
CY2022Q4 us-gaap Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount
FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
3893000
CY2023Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
2771000
CY2022Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
2931000
CY2023Q1 us-gaap Financing Receivable Nonaccrual No Allowance
FinancingReceivableNonaccrualNoAllowance
2771000
CY2022Q4 us-gaap Financing Receivable Nonaccrual No Allowance
FinancingReceivableNonaccrualNoAllowance
2931000
CY2022Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
1000
CY2022Q1 us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
4000
CY2023Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
577238000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
576709000
CY2022Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
167000
CY2022Q4 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
167000
CY2022Q1 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
7246000
CY2022Q1 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Cash Basis Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeCashBasisMethod
4000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
576709000
CY2023Q1 lsbk Financing Receivable Modified Number Of Contracts Subsequent Default
FinancingReceivableModifiedNumberOfContractsSubsequentDefault
0
CY2022Q4 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
95000
CY2023Q1 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
95000
CY2023Q1 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
2100000
CY2022Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
1800000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1684000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1061000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5881849
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5832170
CY2022Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
4239
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5881849
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5836409
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2023Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
633000
CY2022Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
0
CY2023Q1 lsbk Number Of Stock Based Compensation Plans
NumberOfStockBasedCompensationPlans
3
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
11734
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
15.39
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38739000
CY2023Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
38739000
CY2023Q1 us-gaap Marketable Securities
MarketableSecurities
73751000
CY2023Q1 us-gaap Marketable Securities
MarketableSecurities
73751000
CY2023Q1 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
2498000
CY2023Q1 us-gaap Investment In Federal Home Loan Bank Stock Fair Value Disclosure
InvestmentInFederalHomeLoanBankStockFairValueDisclosure
2498000
CY2023Q1 us-gaap Notes Receivable Net
NotesReceivableNet
574408000
CY2023Q1 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
534047000
CY2023Q1 us-gaap Interest Receivable
InterestReceivable
2832000
CY2023Q1 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
2832000
CY2023Q1 us-gaap Derivative Instruments And Hedges
DerivativeInstrumentsAndHedges
223000
CY2023Q1 us-gaap Derivative Assets
DerivativeAssets
223000
CY2023Q1 us-gaap Servicing Asset
ServicingAsset
206000
CY2023Q1 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
206000
CY2023Q1 us-gaap Deposits
Deposits
595207000
CY2023Q1 us-gaap Deposits Fair Value Disclosure
DepositsFairValueDisclosure
596999000
CY2023Q1 us-gaap Shortterm Debt Fair Value
ShorttermDebtFairValue
2030000
CY2023Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
2030000
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
39250000
CY2023Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
38269000
CY2023Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
237000
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Fair Value Disclosure
AccountsPayableAndAccruedLiabilitiesFairValueDisclosure
237000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9633000
CY2022Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
9633000
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
73047000
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
73047000
CY2022Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
2330000
CY2022Q4 us-gaap Investment In Federal Home Loan Bank Stock Fair Value Disclosure
InvestmentInFederalHomeLoanBankStockFairValueDisclosure
2330000
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
573537000
CY2022Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
546278000
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
2796000
CY2022Q4 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
2796000
CY2022Q4 us-gaap Derivative Instruments And Hedges
DerivativeInstrumentsAndHedges
273000
CY2022Q4 us-gaap Derivative Assets
DerivativeAssets
273000
CY2022Q4 us-gaap Servicing Asset
ServicingAsset
209000
CY2022Q4 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
209000
CY2022Q4 us-gaap Deposits
Deposits
570119000
CY2022Q4 us-gaap Deposits Fair Value Disclosure
DepositsFairValueDisclosure
571521000
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
12596000
CY2022Q4 us-gaap Shortterm Debt Fair Value
ShorttermDebtFairValue
12596000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
24950000
CY2022Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
23946000
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
66000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Fair Value Disclosure
AccountsPayableAndAccruedLiabilitiesFairValueDisclosure
66000
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
1589000
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Before Reclassification Adjustments Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
334000
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
1255000
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
-7758000
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Before Reclassification Adjustments Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
-1629000
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-6129000
CY2023Q1 lsbk Other Comprehensive Income Recovery On Previously Impaired Investment Securities Included In Net Income Before Tax
OtherComprehensiveIncomeRecoveryOnPreviouslyImpairedInvestmentSecuritiesIncludedInNetIncomeBeforeTax
3000
CY2023Q1 lsbk Other Comprehensive Income Recovery On Previously Impaired Investment Securities Included In Net Income Tax
OtherComprehensiveIncomeRecoveryOnPreviouslyImpairedInvestmentSecuritiesIncludedInNetIncomeTax
-1000
CY2023Q1 lsbk Other Comprehensive Income Loss Reclassification Adjustment For Recovery On Previously Impaired Investments Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForRecoveryOnPreviouslyImpairedInvestmentsIncludedInNetIncomeNetOfTax
2000
CY2022Q1 lsbk Other Comprehensive Income Recovery On Previously Impaired Investment Securities Included In Net Income Before Tax
OtherComprehensiveIncomeRecoveryOnPreviouslyImpairedInvestmentSecuritiesIncludedInNetIncomeBeforeTax
6000
CY2022Q1 lsbk Other Comprehensive Income Recovery On Previously Impaired Investment Securities Included In Net Income Tax
OtherComprehensiveIncomeRecoveryOnPreviouslyImpairedInvestmentSecuritiesIncludedInNetIncomeTax
-1000
CY2022Q1 lsbk Other Comprehensive Income Loss Reclassification Adjustment For Recovery On Previously Impaired Investments Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForRecoveryOnPreviouslyImpairedInvestmentsIncludedInNetIncomeNetOfTax
5000
CY2023Q1 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
1586000
CY2023Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
333000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1253000
CY2022Q1 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-7764000
CY2022Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-1630000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6134000

Files In Submission

Name View Source Status
0001341318-23-000032-index-headers.html Edgar Link pending
0001341318-23-000032-index.html Edgar Link pending
0001341318-23-000032.txt Edgar Link pending
0001341318-23-000032-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lsbk-20230331.xsd Edgar Link pending
lsbk-20230331x10q.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lsbk-20230331x10q_htm.xml Edgar Link completed
lsbk-20230331xex31_1.htm Edgar Link pending
lsbk-20230331xex31_2.htm Edgar Link pending
lsbk-20230331xex32_1.htm Edgar Link pending
lsbk-20230331xex32_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
lsbk-20230331_def.xml Edgar Link unprocessable
lsbk-20230331_lab.xml Edgar Link unprocessable
lsbk-20230331_pre.xml Edgar Link unprocessable
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
lsbk-20230331_cal.xml Edgar Link unprocessable